08/14/2014 - 12:38pm

Amneal Pharmaceuticals announced four new additions to its portfolio of generic drugs, which represent multiple therapeutic categories and account for $900 million annually in U.S. sales, the company said, citing data from IMS Health.

08/14/2014 - 11:11am

The Food and Drug Administration has announced approval for Belsomra (suvorexant) tablets, which are used to treat insomnia.

08/14/2014 - 9:09am

Tummy Co. recently launched a fast-acting liquid antacid in a shot format called Relief OTC, the company announced Wednesday.

08/12/2014 - 9:15am

Sanofi on Tuesday announced that it has launched an authorized generic version of Eloxatin (oxaliplatin injection) through Winthrop U.S., the company’s generics division. 

08/11/2014 - 11:09am

Janssen Pharmaceuticals received approval from the Food and Drug Administration for Invokamet, a fixed-dose therapy that combines canagliflozin and metformin hydrochloride in a single tablet.

08/11/2014 - 8:53am

Mylan announced the launch of capecitabine tablets USP in 150-mg and 500-mg dosage strengths, a generic version of Xeloda tablets from Genentech.

08/08/2014 - 1:33pm

The Food and Drug Administration earlier this week announced approval for Orbactiv (oritavancin), an antibacterial drug used to treat patients with acute bacterial skin and skin structure infections.

08/08/2014 - 10:39am

The BBC on Tuesday reported that a team has developed an app and small lens add-on that allows blood-cell analysis via a smartphone.

08/05/2014 - 12:00pm

Lannett Co. on Monday announced that its abbreviated new drug application for oxycodone hydrochloride capsules, 5 mg, has been approved by the Food and Drug Administration.